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Abstract
Background:  The conjugated linoleic acid (CLA) content of beef can be increased by
supplementing appropriate beef cattle diets with vegetable oil or oil seed. Yet the effect of
consumption of such beef on adipose tissue characteristics is unclear, thus the study was conducted
to compare adipose tissue responses of rats to diets containing beef from steers either not
provided or provided the oil supplements to alter CLA composition of the fat in muscle.
Methods: Effects of feeding synthetic (industrial hydrogenation) CLA or CLA from beef on growth
and adipose tissue responses of weanling, male, Wistar rats (n = 56; 14 per treatment diet) were
investigated in a completely randomized design experiment. Diets were: control (CON) diet
containing casein and soybean oil, synthetic CLA (SCLA) diet; where 1.69% synthetic CLA replaced
soybean oil, two beef-diets; CONM and CLAM, containing freeze dried beef from steers either not
fed or fed 14% sunflower seeds to increase CLA content of beef. Diets were isonitrogenous (20%
protein) and isocaloric. Rat weights and ad libitum intakes were recorded every 2 wk. After 9 wk,
rats were fasted for 24 h, blood sampled by heart puncture, sacrificed, tissue and organs were
harvested and weights recorded. The adipose tissue responses with regard to cellularity and fatty
acid compositions of retroperitoneal and inguinal adipose tissue were determined.
Results: Body weights and gains were comparable, but organ weights as percent of body weight
were greater for rats fed SCLA than CONM. Fasting blood glucose concentration was lower (p <
0.01) in rats fed SCLA than those fed CONM or CLAM. Retroperitoneal and inguinal fat weights,
as percent of body weight were greater (p < 0.01) in rats fed CONM or CLAM than those fed CON
or SCLA diets. Adipocyte numbers were least in retroperitoneal tissue of rats fed SCLA, while
inguinal tissue cell density and total number were lower (p = 0.02) in rats fed CLAM (7.26 × 107
cells/g and 8.03 × 108 cells) than those fed CONM (28.88 × 107 cells/g and 32.05 × 108 cells,
respectively).
Conclusion: Study suggests that dietary CLA either as synthetic or high CLA-beef may alter
adipose tissue characteristics by decreasing the number of adipocytes and by decreasing the size of
the tissue.
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Background
The probable health benefits that could ensue from con-
sumption of the biologically effective isomers of conju-
gated linoleic acids (CLA) has led to studies that could
increase CLA isomers in foods and to documentation of
the effects of consumption of the CLA isomers as synthetic
compounds or as components in food. Among the health
benefits of CLA consumption are the anti-carcinogenic
effects [1-3] and probable anti-atherogenic effects [4,5],
which appear to be related to the effects of the CLA iso-
mers on lipid metabolism. The CLA trans (t)10, cis (c)12
isomer appears to inhibit lipogenesis in mouse cells [6,7]
and human adipocytes [8,9], by affecting differentiation
via gene expression [9-11]. The commonly occurring iso-
mer, the CLA c9, t11 appears to be anti-proliferative to
mouse adipocytes in vitro [8,9,12]. In vivo, total body fat
was reduced when animals were fed a mixture of the two
CLA isomers from synthetic sources [13-17]. Similar
results were reported in some studies with human subjects
[18,19].
The CLA c9, t11 is the major isomer that occurs in rumi-
nant food products, such as milk, beef and mutton [20]
and is produced either by the bacterium Butyrivibrio fibro-
solvens in the rumen [21] or by desaturation of C18:1 t11
at the ninth carbon in muscle, liver or mammary gland
[22]. However, CLA t10, c12 is largely a product of rumen
fermentation [23] and both CLA isomers can accumulate
in fat tissues, with the concentration being affected by the
feed provided to the cattle [24]. The CLA content in meat
of ruminants ranges from 1.7 to 8.5 mg CLA/g lipid
[25,26], depending on species, breed and feeding regimes
[26,27]. The CLA content of beef can be increased by sup-
plementation of appropriate diets with sources of vegeta-
ble oil [27,28]. Although it is difficult to increase the bio-
formed CLA in beef to levels such as to meet recom-
mended intakes for humans, substantial increases can be
achieved by feeding oils high in polyunsaturated fatty
acids (PUFA) to cattle. Furthermore, studies indicate that
substantially lower intakes of bio-formed CLA in foods
could decrease incidence of cancer [29,30] or more effec-
tively reduce proliferation of cancer cells in vitro than syn-
thetic fatty acid mixtures, which are similar to beef fatty
acid composition [31]. In a pilot study, rats consuming a
high CLA beef, produced by feeding cattle a diet supple-
mented with sunflower oil, reduced adipocyte number in
both inguinal (IG) and retroperitoneal (RP) fat pads rela-
tive to rats fed beef from animals not provided the oil sub-
strate [17]. Similarly, even though the dietary
concentrations of the CLA from beef containing diets were
substantially lower than that provided as synthetic CLA, a
reduction in the adipocyte number in the rat adipose tis-
sues was observed and may be due to inhibition of prolif-
eration of adipocytes by the bio-formed CLA.
Therefore, the present study was conducted to determine
the effects on adipose tissue characteristics, of bio-formed
CLA, as beef from steers fed sunflower seeds (SS) at 14%
of diet dry matter [28], in rats and compared to those of
rats fed beef from steers not provided the SS. Included also
were diets with casein as a dietary protein without or with
supplemental synthetic CLA derived from industrial
hydrogenation of vegetable oil. The experiment was con-
ducted using a completely randomized design, where the
diets were provided at 20% protein, to control the dietary
protein content, unlike the previous study where the meat
replaced the casein [17]. The responses investigated were
growth of the rats, relative weights of the tissues such as
muscle, organs and adipose tissues to total body weight
and the adipocytes in two adipose tissues were enumer-
ated. The lipid content and fatty acid composition of the
adipose tissues were also determined.
Methods
Animals and diets
A total of 56 weaned, male Wistar strain rats were
obtained from Charles River, Canada (St. Constant, Que-
bec, Canada) and were housed individually in cages upon
arrival, and provided rat feed pellets and water ad libitum
for five days to allow them to adjust to the new surround-
ings. Rats were randomly allocated to four treatments (n =
14) by weight and maintained on a 12 h light:dark cycle
at 22 ± 2°C and cared for according to the guidelines of
the Canadian Council on Animal Care [32] and the exper-
iment was conducted with the approval of the Institu-
tional Animal Use Committee (Approval number –
0219).
The diets (Table 1) were: the control diet (CON) – com-
posed of purified ingredients (AIN-93 diet) with casein as
the protein source; the synthetic CLA diet (SCLA) – which
was the CON diet where 1.69% of the soybean oil was
replaced with an equivalent amount of synthetic CLA mix-
ture; the control meat diet (CONM) – which employed
freeze dried beef from animals not fed supplemental SS
(control beef) and the CLA beef diet (CLAM) – which con-
tained freeze dried beef from cattle fed 14% SS to elevate
the CLA and PUFA contents [28] relative to the control
beef. In the meat diets the beef from the two sources
replaced the casein and soybean oil to the extent necessary
to meet the protein and fat concentration of the diets. The
synthetic CLA used in this study was a feed-grade CLA
containing 60% CLA, of which 53% was CLA c9, t11 and
44% was the CLA t10, c12 isomer, and trace amounts of
the other CLA (Bioriginal Food & Science Corp., Saska-
toon, Canada).
Body weight was recorded every two weeks, while feed
was provided ad libitum and weighed in every second day.
The residual feed and the rats were weighed on the sameNutrition & Metabolism 2009, 6:19 http://www.nutritionandmetabolism.com/content/6/1/19
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day. Eight weeks post initiation of the experiment, over
the following two weeks, the animals were sacrificed after
a 24 h feed withdrawal prior to the day of euthanasia.
Each day, the heaviest rat fed from each diet, was sedated
with isoflourine and blood was collected by heart punc-
ture and then euthanized by carbon dioxide suffocation
prior to processing for tissue collection.
Blood and tissue sampling
Serum was harvested from trunk blood samples with a
minimal lapse in time and used for determination of glu-
cose, triglycerides and cholesterol concentrations. The
fresh rat carcasses were weighed after decapitation. The
heart, liver, kidney, inguinal and retroperitoneal fat pads
and the soleus and gastrocnemius muscles from the right
half of the carcass were dissected and weighed. Weights of
the heart, liver, kidney and the tissues are reported as
actual weight and as a percentage of the body weight in
order to determine if the diets influenced development of
particular organs. Fresh fat tissues were sampled and proc-
essed for determination of cell number and the remaining
adipose tissue samples were stored at -20°C until analyses
for fat content and fatty acid composition.
Adipocyte enumeration in retroperitoneal and inguinal 
adipose tissues
Adipocytes in the fat pads were enumerated after fixing
approximately 80 mg of fresh tissue in osmium tetroxide
[33] after removal of blood cells, stromal vascular cells
and pre-adipocytes. The fixed cells that passed through a
240 μmesh [34] were enumerated after appropriate dilu-
tions [17]. The cells were enumerated using a particle
counter (Coulter counter, Model ZBI, Coulter Electronics
Inc. FL, USA) after standardizing the equipment with
hematology controls (Para 12, Streck Laboratories, Inc.,
NE, USA).
Fat extraction and fatty acids analysis
Lipids from fat tissues, from half the rats (n = 7; randomly
selected), from each treatment were extracted according to
the procedures of Jiang and coworkers [35] with modifi-
cations. Briefly, 15 mL of isopropanol was added to a test
tube containing the tissue sample (1.0 g) and then
homogenized (Polytron PT 10–35, Kinematic AG, Swit-
zerland) at high speed for 15 sec. A further 10 mL of hex-
ane was added and homogenized for 15 seconds. The
homogenized mixture was filtered through Whatman fil-
ter paper. The above procedure was repeated twice with
two, 10 mL portions of hexane-isopropanol (v:v; 10:15).
Then 8 mL of aqueous sodium sulfate solution (66.8 g
Table 1: Dietary ingredients and nutrient composition
Treatment diets
CON SCLA CONM CLAM
Ingredient (g/10 kg of diet)
L-cystine* cat # 101444 30.0 30.0 30.0 30.0
Corn starch* cat# 902956 5288.0 5277.0 5090.0 5001.0
Alphacel* cat # 900453 500.0 500.0 500.0 500.0
Vitamin mix* cat # 960402 100.0 100.0 100.0 100.0
Mineral mix* cat # 960400 351.0 351.0 351.0 351.0
Choline bitartrate* cat # 101384 25.0 25.0 25.0 25.0
Casein vitamin-free*cat #904520 1950.0 1950.0 1100.0 537.0
Sucrose* cat # 902978 1000.0 1000.0 1000.0 1000.0
Soybean oil* cat #104687 656.0 498.0 0.0 0.0
Synthetic CLA^ 0.0 169.0 0.0 0.0
Control beef 0.0 0.0 1804.0 0.0
High CLA beef 0.0 0.0 0.0 2456.0
Nutrient composition
DM % 93.5 93.7 94.0 94.0
Total lipid (%DM) 7.3 7.3 5.7 7.9
Total protein (%DM) 19.6 20.1 19.9 21.9
Gross energy (Kcal/g DM) 4.34 4.22 4.37 4.24
*purchased from MP BioMedicals with catalog number (cat #)
^purchased from Bioriginal Food and Sceince Corporation, Saskatoon – Contained 60% Conjugated linoleic acid (CLA) with 53%CLA cis (c)9, trans 
(t)11 and 44% CLA t10, c12 isomers.
Control beef – beef from steers not provided sunflower seeds (SS) during their production, with composition; 97% dry matter (DM), 52.6% protein 
and 38.8% lipids in DM.
High CLA Beef-beef from steers fed 14% SS during their production with composition; 95% dry matter (DM), 60.6% protein and 28.5% lipids in DM.
CON – Control diet, SCLA – diet with 1.69% synthetic CLA replacing and equivalent amount of the soybean oil, CONM – Diet containing control 
beef, CLAM – diet containing high CLA beef.Nutrition & Metabolism 2009, 6:19 http://www.nutritionandmetabolism.com/content/6/1/19
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Na2SO4/L of distilled water) was added to the filtrate and
thoroughly mixed. The test tube containing the solution
was centrifuged at 1100 rpm (640 × g) for 10 min. The
hexane layer was collected into pre-weighed test tubes,
and evaporated under nitrogen completely to obtain the
lipids. The residual fat with the tube was weighed to cal-
culate the fat content of the sample.
A combined base/acid methylation was used to prepare
the fatty acid methyl esters [36]. Briefly, about 20 mg of fat
from the tissue samples were accurately weighed into test
tubes. Then 2 mL sodium methoxide (Sigma-Aldrich Inc.,
Oakville, ON) was added, capped and vortexed for 1 min
and incubated in a 50°C oven for 10 min. After incuba-
tion, 1 mL boron triflouride (14% in methanol, w:v,
Sigma-Aldrich Inc., Oakville, ON) was added, capped and
vortexed for 1 min and again incubated in a 50°C oven for
an additional 10 min. After removal from the oven, 5 mL
de-ionized water was added and vortexed followed by 5
mL hexane and vortexed. When the layers separated, an
aliquot of the top layer was removed and transferred into
a 2 mL gas chromatographic vial, capped and stored at -
40°C until analyzed. Nonadecanoic acid methyl ester
(C19:0; Nu-Chek Prep, Inc., MN, USA) was added to the
fat samples as an internal standard.
Fatty acid methyl esters were quantified using a gas chro-
matograph (Hewlett Packard GC System 5890; Missis-
sauga, ON) equipped with a flame ionization detector
and SP-2560 fused silica capillary column (100 m with
0.2-μm film thickness; Supelco Inc., Oakville, ON). Sam-
ples were loaded on to the column via 1 μL splitless injec-
tions [37]. The initial oven temperature (120°C) was held
for 15 min and then increased at 5°C/min to 160°C, and
held for 15 min. Next the temperature was increased at
4°C/min to 240°C and held for 30 min. Inlet and detec-
tor temperatures were maintained at 220°C, and 275°C,
respectively. Helium carrier gas flow rate through the col-
umn was 1.7 mL/min. Hydrogen flow to the detector was
34 mL/min, air flow rate was 320 mL/min and helium
make-up gas flow rate was 29 mL/min. Peaks in the chro-
matograms were identified and quantified using pure
methyl ester standards (Sigma-Aldrich Inc., Oakville,
ON).
Diet and blood component (glucose, cholesterol and 
triglycerides) analyses
Dietary Nitrogen was determined using the automated
combustion technique ([38]; Carlo Erba®, Milan, Italy)
and crude protein was calculated as the product of the
Nitrogen value and 6.25, while fat content of the diets was
determined by extraction of dried samples with di-ethyl
ether for a minimum of six hours in a Goldfisch apparatus
[39]. The gross energy in diets was determined by calorim-
etry ([17]; LECO AC-300, Leco Corporation, Michigan,
USA). Blood glucose, cholesterol and triglycerides were
analyzed on a VetTest 8008, Chemistry Analyzer (IDEXX
Laboratories, Inc., Westbrook, Maine, USA) by using the
slides for GLU (Code 2376), CHOL (Code 2358) and
TRIG (Code 2396) (IDEXX Laboratories, Inc., Westbrook,
Maine, USA), respectively after calibrating the equipment
with appropriate standards.
Statistical analysis
The data were analyzed for variance as a completely rand-
omized design experiment, with four dietary treatments
and n = 14 for each treatment for the growth data and with
n = 7 for the fatty acid analyses. The analysis of variance
was conducted using the PROC MIXED procedure of SAS
(Statistical Analyses Systems Institute, Cary, NC) for the
rat body weight, growth rate, feed consumption, the
blood components (glucose, cholesterol and triglycer-
ides), organ, muscle and adipose tissue (retroperitoneal
and inguinal) weights and fatty acid composition of adi-
pose tissues. Initial body weight and number experimen-
tal days were used as covariates for the growth and feed
consumption data. The fixed effect and the differences
among treatments were considered significant at proba-
bility values of p ≤ 0.05.
Results
Diet composition and growth performance of rats
The fat and protein content and gross energy of the diets
were comparable (Table 1), because diets were prepared
to be isonitrogenous and isocaloric, although the source
of protein and energy varied among the diets. The concen-
tration ranking, from high to low, in the experimental
diets for both CLA isomers was SCLA, CLAM, CONM and
CON (Table 2).
The meat (beef) diets (CONM and CLAM) contained four
to five fold more saturated (C16:0 and C18:0) and
monounsaturated fatty acids (MUFA) (C18:1 c9) but sub-
stantially less PUFA (C18:2 and C18:3) relative to the
CON and SCLA diets, and were reflective of the differ-
ences in fatty acid composition between soybean oil and
beef fat, which were the principal sources of fat in the
diets. Vaccenic acid (C18:1 t11) concentration of the
CLAM diet, which contained the high CLA beef was (5.5%
of fatty acids) higher than of the CON, SCLA diets (0.01%
of fatty acids) or the CONM diet, which contained the
control beef (0.19% of fatty acids).
Body weights, intakes and growth rates have been
reported for the first six weeks and for the duration of the
feeding trial (Table 3). Although rat body weight differ-
ences at the start of the experiment were not evident, by
six weeks the rats fed the SCLA diet were lighter (p = 0.02)
than those fed the other diets, but this significance did not
persist until the end of the study, which was nine weeksNutrition & Metabolism 2009, 6:19 http://www.nutritionandmetabolism.com/content/6/1/19
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on average, but rats fed the SCLA diet tended (p = 0.07) to
have a lower body weight. Growth rates followed the
same pattern as the body weights, which may be related to
lower total feed consumed by rats fed the CON or SCLA
diets relative to those fed the CONM or CLAM diets. The
over all protein consumed (product of feed consumed
and diet-protein content/100) was higher for rats fed the
meat containing diets (CONM or CLAM) than either the
CON or the SCLA diet. The energy consumed (product of
the feed consumed and the energy value of the diets) was
lower for the CON and SCLA diets relative to that of the
CONM and CLAM diets. These differences affected the
energy requirement per gram of body weight gain. Thus
efficiency of energy utilization for weight gain was better
(lower energy required for each gram of gain) in rats fed
the CON and SCLA diets than of those fed the CONM and
CLAM diets. It was clear that animals consumed more of
the meat containing diets relative to the casein containing
diets.
Carcass, organ and muscle weights
The carcass weights, similar to the final body weights of
the rats were not affected by the different diets and only
rats fed the SCLA diet tended (p = 0.11) to have a lower
carcass weight (Table 4). Differences due to diet were not
observed for organ weights, but when expressed as a per-
cent of body weight, rats fed the CONM diet had lower
percentages for heart, liver and kidney than for rats fed the
Table 2: Fatty acid (FA) composition of lipids in diets
Treatment diets
Fatty acids* (mg/100 mg) CON SCLA CONM CLAM
C14:0 0.06 0.09 5.26 5.47
C14:1 c 0.00 0.00 0.84 0.69
C16:0 5.09 5.44 24.32 23.06
C16:1 c 0.04 0.04 3.57 2.76
C18:0 3.03 3.05 15.92 19.21
C18:1 t11 0.01 0.01 0.19† 5.55
C18:1 c9 11.16 11.54 37.85 30.68
C18:2 c9, c12 77.74 69.20 5.56 8.34
C18:3 1.62 1.42 0.10 0.11
CLA c9, t11 0.03 4.64 0.29 0.49
CLA t10, c12 0.00 3.20 0.02 0.04
C20:4 0.02 0.03 0.07 0.08
UNS/Total FA 0.91 0.91 0.53 0.51
UNS/SAT 10.75 10.21 1.14 1.05
C18:2/C18:3 48.04 54.43 58.61 85.96
*denoted as Carbon chain length: number of unsaturated bonds in 
trans (t) or cis (c) position and location
† Calculated from value for control beef in (Shah et al., 2006)
UNS – unsaturated FA, SAT – Saturated FA
CON – Control diet, SCLA – diet with 1.69% synthetic CLA replacing 
equivalent amount of the soybean oil, CONM – Diet containing 
control beef (see table 1), CLAM – diet containing high CLA beef (see 
table 1).
Table 3: Effects of synthetic CLA or CLA beef on rat growth performance
Treatment diets
CON SCLA CONM CLAM
Initial BW (g) 85.5 ± 2.2 85.6 ± 2.0 86.0 ± 2.3 86.3 ± 2.1
BW at 6 wks (g) 410.6 ± 7.6B 387.0 ± 7.6A 413.1 ± 8.0B 421.6 ± 9.6B
Final BW at 9 wks (g) 486.1 ± 14.7 470.2 ± 11.7 500.3 ± 13.3 509.5 ± 18.4
DWG: 1–42 d (g/d) 7.7 ± 0.2B 7.2 ± 0.2A 7.8 ± 0.2B 8.0 ± 0.2B
DWG: overall (g/d) 6.4 ± 0.1 6.2 ± 0.1 6.7 ± 0.2 6.8 ± 0.2
FI: 1–42 d (g) 1053 ± 46A 932 ± 34A 1333 ± 81B 1294 ± 53B
FI: overall (g) 1708 ± 74A 1566 ± 95A 2149 ± 159B 2173 ± 156B
Daily FI (g/d) 27.1 ± 1.1A 24.9 ± 1.1A 34.0 ± 2.5B 33.8 ± 1.9B
Protein intake (g) 333.2 ± 15.0A 314.8 ± 19.1A 412.9 ± 26.5B 458.5 ± 24.1B
GE intake (kcal) 7381 ± 331A 6608 ± 400A 9066 ± 583B 8887 ± 466B
GE/BWG: overall (kcal/g) 18.5 ± 0.85A 17.1 ± 0.64A 22.1 ± 1.05B 21.7 ± 0.94B
CLA c9, t11 consumed (g) 0.04 5.31 0.34 0.81
CLA t10, c12 consumed (g) - 3.45 0.02 0.06
A, B: Means (± standard error) in a row denoted by a different letter differ (p < 0.05); n = 14
BW – Body weight, DWG – daily weight gain, FI – feed intake, GE – gross energy,
CON – Control diet, SCLA – diet with 1.69% synthetic CLA replacing and equivalent amount of soybean oil, CONM – Diet containing control beef 
(see table 1), CLAM – diet containing high CLA beef (see table 1).
Protein intake – product of diet protein content and FI overall/100.
GE intake – product of diet GE and FI overall.
Consumed CLA c9, t11 or CLA t10, c12 – calculated from means, CLA c9, t11 or CLA t10, c12 percent in diet × diet fat content × FI overall/
10000; respectively.Nutrition & Metabolism 2009, 6:19 http://www.nutritionandmetabolism.com/content/6/1/19
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SCLA diet. Organ weight as percent of body weight in rats
fed the CON or CLAM diets did not differ, except for liver
weight as percent of body weight, where this value was
greater in the rats fed the CON and SCLA diets than those
observed for the rats receiving the CONM diet. The diets
did not affect the weights of the soleus and gastrocnemius
muscles or the percentage of the muscle weights to body
weight.
Adipose tissue weights and adipocyte number
The RP fat pad weights were lowest (p < 0.01) in rats fed
the SCLA diet at 8.68 g and lower than that of rats fed the
CON diet (12.85 g), which was lower than of rats fed the
meat containing diets (16.86 and 16.98 g for the rats fed
CONM and CLAM diets, respectively), which were not dif-
ferent from each other. The weights for this tissue as a per-
cent of body weight followed the same pattern as tissue
weights. Because of large standard errors, differences in
adipocyte density (n × 107/g) of the retroperitoneal adi-
pose tissue of rats fed the different diets were not
observed. However, when the cell density was multiplied
by the tissue weight to obtain total cells in tissue (n × 108;
Figure 1), the provision of either the CON or the CLAM
diets led to similar and the highest (p = 0.04) cell num-
bers, which were greater than of rats fed the SCLA diet.
The weight of the IG tissue of rats fed the CLAM diet was
higher (p < 0.01) than that of rats fed the CON, which was
greater (p = 0.01) than that of rats fed the SCLA diet.
Inguinal tissue weights as percent of body weight was
greatest for rats fed either CONM or the CLAM diets,
which were greater than of rats fed the CON diet and that
of rats fed the SCLA was the least (p < 0.01). Adipocyte
density was higher (p < 0.01) in rats fed the SCLA or the
CONM diets and greater (p < 0.01) than in rats fed the
CLAM diet as a result the total cells were lower (p = 0.02)
in rats receiving the CLAM relative to those fed the CONM
diet (Figure 1).
Blood glucose, cholesterol and triglycerides
The fasting blood glucose concentration (Table 4) of rats
fed the SCLA was lower (p < 0.01) than of rats fed meat
containing diets and the CON diet. Differences in fasting
cholesterol were not observed for the rats, despite sub-
stantial variation in protein source and fat type in the
diets. However in rats fed the CLAM diet a trend (p = 0.07)
towards higher triglycerides was observed relative to that
in rats fed the other diets.
Table 4: Carcass components, cellularity of fat pads and concentrations of blood glucose, cholesterol and triglycerides in the rats
Treatment diets
CON SCLA CONM CLAM
Carcass weight (g) 395.33 ± 11 374.73 ± 10 392.90 ± 10 402.86 ± 13
Heart (g) 1.50 ± 0.03 1.51 ± 0.04 1.44 ± 0.04 1.53 ± 0.04
Heart/BW (%) 0.31 ± 0.01AB 0.32 ± 0.01B 0.29 ± 0.01A 0.30 ± 0.01AB
Liver (g) 13.74 ± 0.31 13.42 ± 0.29 13.18 ± 0.53 14.06 ± 0.53
Liver/BW (%) 2.85 ± 0.08B 2.86 ± 0.06B 2.64 ± 0.09A 2.77 ± 0.07AB
Kidney (g) 3.13 ± 0.08 3.22 ± 0.08 3.11 ± 0.06 3.17 ± 0.06
Kidney/BW (%) 0.65 ± 0.02AB 0.69 ± 0.02B 0.62 ± 0.01A 0.63 ± 0.02A
Soleus (g) 0.33 ± 0.10 0.20 ± 0.01 0.22 ± 0.01 0.21 ± 0.01
Soleus/BW (%) 0.06 ± 0.016 0.04 ± 0.002 0.04 ± 0.001 0.04 ± 0.002
Gastrocnemius (g) 2.73 ± 0.12 2.57 ± 0.09 2.72 ± 0.06 2.84 ± 0.06
Gastrocemius/BW (%) 0.57 ± 0.03 0.55 ± 0.02 0.55 ± 0.02 0.56 ± 0.02
Retroperitoneal fat (RP)
Weight (g) 12.85 ± 1.26B 8.68 ± 1.07A 16.86 ± 1.58C 16.98 ± 1.91C
RP/BW (%) 2.61 ± 0.22B 1.80 ± 0.19A 3.32 ± 0.26C 3.22 ± 0.25C
n × 107 cells/g 26.90 ± 7.16 9.38 ± 2.10 22.28 ± 5.95 23.39 ± 4.44
Inguinal fat (IG)
Weight (g) 10.12 ± 0.98AB 7.62 ± 0.48A 11.69 ± 0.86B C 12.80 ± 1.54C
IG/BW (%) 2.06 ± 0.18B 1.60 ± 0.07A 2.31 ± 0.13C 2.42 ± 0.21C
n × 107 cells/g 20.15 ± 4.18AB 26.01 ± 5.94B 28.88 ± 5.56B 7.26 ± 1.28A
Blood components
Glucose (g/L) 1.27 ± 0.04 bB 1.17 ± 0.05A 1.39 ± 0.05B 1.37 ± 0.06B
Cholesterol (g/L) 0.60 ± 0.03 0.59 ± 0.05 0.59 ± 0.04 0.63 ± 0.07
Triglycerides (g/L) 0.73 ± 0.08 0.79 ± 0.06 0.77 ± 0.06 1.04 ± 0.13
A-C: Means (± standard error) in a row denoted by a different letter differ (p < 0.05); n = 14
BW – body weight
CON – Control diet, SCLA – diet with 1.69% synthetic CLA replacing an equivalent amount of soybean oil, CONM – Diet containing control beef 
(see table 1), CLAM – diet containing high CLA beef (see table 1).Nutrition & Metabolism 2009, 6:19 http://www.nutritionandmetabolism.com/content/6/1/19
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Fat content and fatty acids composition of adipose tissues
Fat content of the RP adipose tissue was comparable for
the rats fed the different diets and ranged between 80.15
to 87.68% (Table 5) and that of the IG tissue ranged
between 76.94% for the rats fed the SCLA diet and
85.09% fat content of rats fed the CON diet (Table 6). The
fat content of the IG tissue of rats fed the SCLA diet tended
(p = 0.08) to be lower than of rats fed the CON diet while
differences were not observed for rats fed the other diets.
The fatty acid profiles of the two fad pads were compara-
ble and influenced by the fatty acid composition of the
diets provided to the rats. Although the total profiles are
reported in the tables, only relevant components will be
highlighted in this section. In the RP adipose tissue the
major saturated fatty acid was C16:0, which is indicative
of de novo synthesis in the animals fed the CON and SCLA
diets and accounted for a quarter of the total fatty acids
detected and differences due to diet were not evident. The
range for C18:0 was from 3.47 to 6.00% and the values
were higher (p < 0.01) in rats fed the CLAM diets relative
to the others, which is suggestive of the extent of biohy-
drogenation of the oil from the SS fed to the beef steers to
produce the high CLA beef. A greater amount of the high
CLA beef was incorporated in the CLAM relative to the
control beef in the CONM diet, due to the difference in fat
content of the two meats, further elevating the supply of
saturated fatty acids in the diet. For the same reason the
total unsaturated fatty acids and their ratio to the satu-
rated fatty acids were least in the RP tissues of rats fed the
CLAM diet relative to those fed the CON diet and were
reflective of the fatty acid composition of the fat source
employed in the preparation of the diets. The C18:1 c9,
C18:2 c9, 12 and C18:3 c9, 12, 15 concentrations in the
RP fat were reflective of the principal fat source in the diets
and C18:1 concentrations were higher in animals fed the
control beef (CONM) while the diets prepared with soy-
bean oil had higher levels of the C18:2 and C18:3.
Although the diets did not contain the elongated ω-3 fatty
acids (C22:5 and C22:6) these were detected in the RP fat
suggesting significant endogenous synthesis of these fatty
acids. Both CLA isomers were found in this tissue, and
were affected by dietary treatment, thus rats fed the SCLA
diet had substantially higher (p < 0.01) concentrations of
these fatty acids relative to rats fed the other diets. The CLA
c9 t11 was higher in rats fed the beef containing diets rel-
ative to those receiving the CON diet, but the rats fed the
CLAM diet had only numerically higher amounts in the
retroperitoneal tissue relative to those fed the CONM diet.
Although not significant, the concentration of C18:1 t11
was twice as high in the tissues of rats fed the CLAM diet
relative to those fed the CONM diet.
The fatty acid composition of the IG fat pads (Table 6) was
similar to that of RP pads. However, unlike observations
in the RP fat pads, the C14:0 tended (p = 0.11) to be ele-
vated in rats fed the beef containing diets (CONM and
CLAM) relative to the concentrations of this fatty acid in
Comparison of the total number of adipocytes in fat tissues from rats fed with various diets Figure 1
Comparison of the total number of adipocytes in fat tissues from rats fed with various diets. A, B: Means (± stand-
ard error) denoted by a different letter differ (p < 0.05); n = 14. CON – Control diet, SCLA – diet with 1.69% synthetic CLA 
replacing and equivalent amount of soybean oil, CONM – Diet containing control beef (from steers not provided sunflower 
seeds (SS) during their production, with composition; 97% dry matter (DM), 52.6% protein and 38.8% lipids in DM), CLAM – 
diet containing high CLA beef (from steers fed 14% SS during their production with composition; 95% dry matter (DM), 60.6% 
protein and 28.5% lipids in DM).
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those fed the CON diet. Among the other saturated fatty
acids, C16:0 comprised about 25% of the total fatty acids.
The concentrations of the C18:0 were highest in rats fed
the CLAM diet. In the IG adipose tissue the ratios of
unsaturated fatty acids to total fatty acids, or to saturated
fatty acids were higher (p = 0.02, < 0.01) in the rats fed the
CON diet relative to those fed the CLAM diet. The concen-
trations of C18:1 c9; C18:2 c9, 12; and C18:3 c9, 12, 15
were as observed for the RP fat pad. The CLA isomers were
highest in rats fed the SCLA diet, as observed in the RP tis-
sue, and rats fed the CLAM diet demonstrated only
numerical increases in concentrations of the CLA c9, t11
and CLA t10, c12. Although only a trend (p = 0.14), rats
fed the CLAM diet had five times more C18:1 t11 than rats
fed the CONM diet.
The ratios of C18:2 to C18:3 were higher in the diets than
in the two adipose tissues that were studied and may be
largely due to the presence of elongated ω-3 fatty acids in
the tissues but not in the diets. In the diets, the ratios
ranged between 48.04 and 85.96 for the CON and CLAM
diets respectively, but this ratio ranged between 9.99 and
25.66 in the RP fat pad and 9.18 and 16.66 in the IG fat
pads for rats fed the same diets and differed significantly.
Discussion
Among the objectives of the study was the establishment
of the effects of the diet containing beef with the bio-
formed CLA under conditions where the diets were bal-
anced for protein and fat content, but the nature of the
proteins and the fatty acid composition of the fat varied
among the diets on adipose tissue characteristics. The
inclusion rate of the synthetic CLA was high and compa-
rable to that in the previous study and represented the rec-
ommended level of dietary incorporation for CLA. The
increase in content of the two CLA isomers in the diets
containing the high CLA beef was comparable to concen-
trations achieved previously [17], even though it was nec-
essary to add casein in the CLAM and CONM diets to
achieve the 20% protein without affecting the fat content
of the diets.
The feed consumption of the CON and SCLA was less
than of CONM or CLAM diets and the results are in con-
currence with previous reports [40] which indicate poor
consumption rates for low protein or non-appetizing
diets, indicating a strong preference for meat containing
diets.
Although carcass weights were greater for rats in the
present study for nine week old rats than those reported
for 11 wk old rats, the liver weights were lower than
Table 5: Effects of synthetic CLA or high CLA beef on fatty acid composition of retroperitoneal fat of the rats
Treatment diets
CON SCLA CONM CLAM
Lipid (% tissue) 81.33 ± 2.32 80.15 ± 3.80 84.54 ± 2.43 87.68 ± 5.24
Fatty acid concentration (mg/100 mg of detected fatty acids)
C14:0* 1.13 ± 0.096 1.06 ± 0.065 1.67 ± 0.089 1.99 ± 0.103
C14:1 c 0.01 ± 0.004A 0.01 ± 0.005A 0.46 ± 0.016B 0.44 ± 0.015B
C16:0 22.92 ± 0.83 25.37 ± 0.51 23.88 ± 0.48 25.28 ± 0.71
C16:1 c 4.79 ± 0.22B 2.88 ± 0.14A 6.78 ± 0.28C 6.31 ± 0.32C
C18:0 3.74 ± 0.13A 3.47 ± 0.30A 4.63 ± 0.33B 6.00 ± 0.26C
C18:1 t11 0.00 ± 0.73 0.65 ± 0.63 1.01 ± 0.63 2.14 ± 0.83
C18:1 c9 28.86 ± 0.66A 25.10 ± 0.77A 52.48 ± 0.91B 48.31 ± 1.54B
C18:2 c9, c12 30.49 ± 2.46C 26.60 ± 1.40B 2.58 ± 0.36A 3.50 ± 0.39A
C18:3 3.0 ± 0.07C 2.33 ± 0.03B 0.17 ± 0.01A 0.14 ± 0.01A
CLA c9, t11 0.01 ± 0.002A 4.50 ± 0.408C 0.38 ± 0.011B 0.60 ± 0.041B
CLA t10, c12 0.10 ± 0.003A 3.16 ± 0.081B 0.23 ± 0.006A 0.19 ± 0.007A
C20:4 0.41 ± 0.17 0.21 ± 0.014 0.28 ± 0.003 0.21 ± 0.010
C22:5 0.18 ± 0.007 0.39 ± 0.004 0.49 ± 0.000 0.42 ± 0.000
C22:6 0.78 ± 0.011 0.60 ± 0.007 0.81 ± 0.000 0.86 ± 0.000
UNS/Total FA 0.72 ± 0.02B 0.69 ± 0.01AB 0.68 ± 0.01AB 0.65 ± 0.01A
UNS/SAT 2.60 ± 0.19B 2.27 ± 0.16AB 2.18 ± 0.06AB 1.91 ± 0.09A
C18:2/C18:3 9.99 ± 0.58A 14.43 ± 0.27AB 20.36 ± 3.15BC 25.66 ± 2.42C
A-C: Means (± standard error) in a row denoted by a different letter differ (p < 0.05); n = 7
*denoted as Carbon chain length: number of unsaturated bonds in trans (t) or cis (c) position and location
CON – Control diet, SCLA – diet with 1.69% synthetic CLA replacing an equivalent amount of soybean oil, CONM – Diet containing control beef 
(see table 1), CLAM – diet containing high CLA beef (see table 1).Nutrition & Metabolism 2009, 6:19 http://www.nutritionandmetabolism.com/content/6/1/19
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reported weights [16] and may be related to age of the rats
at euthanasia or differences between strains of rats
(Sprague-Dawley vs Wistar). Yet, among the same strain
of rats, the liver weights were lower in the present study,
in spite of the rats being older than those in the previous
study [17]. It may be indicative of attainment of mature
size, after which a further increase in organ weight may
not occur, even though body weight continues to increase
in response to feed and age. The weight increase response
may register in weight of adipose tissue.
The RP adipose tissue weights observed in the present
study were greater than those reported [16], even though
the rats were older in their study and attributable to being
a characteristic of Sprague-Dawley rats as compared to
Wistar rats. However, relative to the previous report [17]
for Wistar rats, the weights of this tissue in this study were
higher, which could be an age of rat related factor (six vs
nine weeks). The synthetic CLA has always been known to
reduce the weight and cell number of the RP fat pads [17]
and the effect on this tissue in the present study was con-
sistent with previous observations.
Inguinal adipose tissue weights were higher than those
reported [16,17] but similar to those reported for IG tissue
weights of rats fed high fat diets [34], probably age and
strain of rats may be operative for the variations observed.
The relationship among diet components, tissue cell
number and tissue weight is unclear. Mir and co-workers
[17] observed that cell density and total cell number in the
two adipose tissues were markedly greater in rats fed sun-
flower oil in comparison to those fed soybean oil, yet tis-
sue weights were similar, and even though synthetic CLA
provision decreased RP tissue weights, total cell number
were not different from those of rats fed the control diet.
Furthermore, synthetic CLA failed to affect the IG adipose
tissue weight or cell density when compared to the control
diet in the previous study [17] and similarly, IG tissue cell
number were comparable for rats fed CON and SCLA diets
in the present study. However, when rats were fed the
CLAM diet the tissue weights were comparable to those of
rats fed the CONM but the cell density and total number
were markedly lower (p < 0.01) and consistent with previ-
ous observations for the IG tissue [17]. It is of importance
to note that the total CLA c9, t11 consumed over the dura-
tion of the trial by rats fed the CLAM diet was 0.81 g and
the highest between rats fed the beef containing diets.
Also the dietary C18:1 t11 was highest in this diet; and it
is known that this fatty acid contributes to endogenous
synthesis of CLA c9, t11 [41]. The CLA c9, t11 is an anti-
proliferative, thus its anticarcinogenic effect, and in vitro,
it appears to inhibit cell proliferation of preadipocytes
[6,7], but encourages fat accumulation in the remaining
cells, which may explain the observed effect on cell den-
sity and IG tissue weight of rats fed the CLAM diet. Previ-
Table 6: Effects of synthetic CLA or high CLA beef on fatty acid composition of inguinal fat of the rats
Treatment diets
CON SCLA CONM CLAM
Lipid (% tissue) 85.09 ± 2.2 76.94 ± 1.68 81.30 ± 2.50 84.22 ± 4.42
Fatty acid concentration (mg/100 mg of detected fatty acids)
C14:0* 0.58 ± 0.094 1.48 ± 0.441 2.03 ± 0.097 2.48 ± 0.39
C14:1 c 0.00 ± 0.005A 0.00 ± 0.005A 0.55 ± 0.013B 0.50 ± 0.42B
C16:0 22.97 ± 1.59 25.45 ± 1.08 23.50 ± 0.29 24.30 ± 2.25
C16:1 c 5.14 ± 0.23AB 3.53 ± 0.16A 8.05 ± 0.29C 7.56 ± 0.66BC
C18:0 3.51 ± 0.29A 3.02 ± 0.07A 4.15 ± 0.40AB 5.04 ± 0.27B
C18:1 t11 0.42 ± 0.91 0.64 ± 1.72 0.71 ± 1.17 3.67 ± 1.21
C18:1 c9 27.56 ± 2.32A 24.53 ± 2.01A 52.23 ± 0.73C 46.44 ± 4.10B
C18:2 c9, c12 30.77 ± 2.28B 26.63 ± 1.77B 2.87 ± 0.19A 3.50 ± 0.99A
C18:3 3.25 ± 0.06C 2.58 ± 0.05B 0.18 ± 0.01A 0.29 ± 0.02A
CLA c9, t11 0.00 ± 0.04A 4.54 ± 0.08C 0.42 ± 0.01B 0.79 ± 0.09B
CLA t10, c12 0.19 ± 0.002A 2.92 ± 0.031B 0.08 ± 0.002A 0.32 ± 0.008A
C20:4 0.53 ± 0.026B 0.27 ± 0.024A 0.09 ± 0.015A 0.05 ± 0.012A
C22:5 0.42 ± 0.005 0.25 ± 0.006 0.16 ± 0.003 0.50 ± 0.001
C22:6 0.63 ± 0.015 0.49 ± 0.009 0.69 ± 0.009 0.80 ± 0.003
UNS/Total FA 0.72 ± 0.01B 0.69 ± 0.01AB 0.69 ± 0.00AB 0.67 ± 0.01A
UNS/SAT 2.61 ± 0.1B 2.24 ± 0.1AB 2.22 ± 0.04AB 2.05 ± 0.1A
C18:2/C18:3 9.18 ± 0.32A 12.94 ± 0.21AB 15.98 ± 2.46B 16.66 ± 4.15B
A-C: Means (± standard error) in a row denoted by a different letter differ (p < 0.05); n = 7
*denoted as Carbon chain length: number of unsaturated bonds in trans (t) or cis (c) position and location
CON – Control diet, SCLA – diet with 1.69% synthetic CLA replacing an equivalent amount of soybean oil, CONM – Diet containing control beef 
(see table 1), CLAM – diet containing high CLA beef (see table 1).Nutrition & Metabolism 2009, 6:19 http://www.nutritionandmetabolism.com/content/6/1/19
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ously Chardigny and co workers [42] have reported that in
some strains of rats the size of the IG tissues was reduced
by dietary synthetic CLA while livers became fat infil-
trated. Although an effect on the liver was not observed in
the present study or in the previous study [17], it appears
that the bio-formed CLA provided as beef affected cell
numbers of this tissue.
The amounts of bio-formed CLA c9, t11 consumed by the
rats through the duration of the study from the CLAM diet
was approximately 15% of the synthetic CLA c9, t11 in
rats fed the SCLA diet, thus, IG fat pad weight was not
affected, but the cell numbers were diminished. The effect
on the decreased cell number is consistent with a previous
observation [17], where the dietary protein was 12%. It
has been observed that the percent reduction in fat mass
of human subjects consuming a CLA triglyceride was a
consistent 8% over a 24-month period relative to only a
5% decline in subjects consuming the CLA free acid [19],
thus it can be hypothesized that the marginal greater effect
of the CLA triglyceride could be due to the effect of the
CLA at the Sn-2 position. Digestion, absorption and prob-
ably utilization of fatty acids in the Sn-2 position are
reported to progresses differently from those in the Sn-1
and Sn-3 position [43]. Chardigny and co-workers [44]
reported that rumenic acid in the Sn-2 position was found
to a greater extent in the carcass, while that from the Sn-1
or 3 positions led to increased yield of energy (recovered
in exhaled carbon dioxide), even though differences in
digestibility of the rumenic acid provided as free fatty acid
or as triacylglycerol did not exist [45]. In earlier studies it
has been reported that the CLA in muscle fat is largely
located at the Sn-2 position [46] unlike that in milk fat
[44]. The location of this fatty acid in the triacylglycerol in
beef may confer increased efficacy and explain the height-
ened responses of cancer protection among milk consum-
ers referred to by Knekt and co-workers [29] and observed
by Hubbard and co-workers [30]. The synthetic and bio-
formed CLA would be absorbed as free fatty acid or as Sn2
mono-acylglycerol, respectively and may bind to different
receptors in RP and IG tissue leading to the differential
response observed in the tissues to the two forms of CLA.
Although similar response has been observed both in this
study and in the previous study [17] the cause for such a
response needs definition.
Transfer of dietary fatty acids to the adipose tissues was
observed in the rats. Greater levels of the C18:1c9 and
C18:0 were observed in rats fed the meat containing diets
with further elevated levels of C18:0 in the rats fed the
CLAM diet indicating the elevated biohydrogenation of
the linoleic acid in the dietary SS provided to the steers
during production of the beef. Since soybean oil was
added to the CON and SCLA diets, greater proportions of
C18:2 and C18:3 were present in both the adipose tissues
than in rats fed the meat containing diets, as has been
observed in pigs [47]. The provision of C18:2 and C18:3
is known to suppress steroyl regulatory element binding
protein -1 leading to reductions in fatty acid synthase gene
transcription [48] and may be associated with the obser-
vation of diminished weight of the RP adipose tissue in
rats fed the CON diet in the present study relative to those
fed the meat containing diets.
It is of interest to mention that even though the casein
diets contained soybean oil, a high-PUFA oil relative to
beef fat, a difference in the fasting plasma cholesterol was
not observed suggesting that the effect of beef on plasma
cholesterol profiles needs to be revisited. There may be
advantage to using animal models which respond to die-
tary alterations through changes in plasma cholesterol
concentration as in humans such as guinea pigs [49] to
assess the value of high CLA beef in controlling plasma
cholesterol and the lipoprotein class in which the choles-
terol occurs. Development of knowledge regarding the
distribution of the cholesterol among the various lipopro-
teins as influenced by high CLA beef would provide the
necessary information to promote the benefits of con-
sumption of beef. Despite substantially higher values for
adipose tissues weights as percent of body weight, fasting
plasma glucose concentrations were similar for rats fed
the CON, CONM and CLAM diets, suggesting that the adi-
pose tissues were equally effective in removing glucose
out of circulation. The low plasma glucose for the rats fed
SCLA may be related to the specific effects of synthetic
CLA on the RP adipose tissue and the diminished intake
of the diet relative to the beef containing diets, leading to
lower glucose load and improved management. The trend
towards the increased plasma triacylglycerol in CLAM fed
rats may be suggestive of lipid saturation of the adipocytes
in either tissue.
Conclusion
Despite the substantially lower concentrations of the CLA
consumed from the high-CLA beef diets, relative to that by
the rats fed synthetic CLA, a decrease in cellularity of the
IG fat depot was observed. The effects observed previously
[17] and the current study, indicate that the bio-formed
CLA affects mainly IG fat pads at substantially lower con-
centrations than synthetic CLA free acid, which appears to
decrease the size and total number of cells in the RP adi-
pose tissue. Although more studies on the effect of CLA
are required in the future, the present study suggests that
dietary CLA from high CLA beef as well as synthetic CLA
may influence lipid storage potential of the adipose tis-
sues through affecting tissue size or cellularity and may
not detrimentally affect plasma cholesterol concentra-
tions.Nutrition & Metabolism 2009, 6:19 http://www.nutritionandmetabolism.com/content/6/1/19
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